Curbstone Financial Management Raised J.M. Smuckers Co (Sjm) (SJM) Stake; 16 Analysts Are Bullish Spark Therapeutics, Inc. (ONCE) Last Week

Among 25 analysts covering Spark Therapeutics (NASDAQ:ONCE), 16 have Buy rating, 2 Sell and 7 Hold. Therefore 64% are positive. Spark Therapeutics had 67 analyst reports since August 21, 2015 according to SRatingsIntel. The stock has “Buy” rating by RBC Capital Markets on Thursday, September 14. The firm has “Buy” rating given on Wednesday, December 13 by Bernstein. The rating was maintained by BMO Capital Markets with “Buy” on Thursday, July 6. Chardan Capital Markets initiated Spark Therapeutics, Inc. (NASDAQ:ONCE) on Wednesday, December 23 with “Neutral” rating. The firm earned “Buy” rating on Monday, June 26 by Stifel Nicolaus. The firm has “Overweight” rating given on Thursday, January 25 by Barclays Capital. As per Tuesday, April 12, the company rating was initiated by Evercore. As per Monday, September 4, the company rating was maintained by Jefferies. Roth Capital maintained Spark Therapeutics, Inc. (NASDAQ:ONCE) rating on Monday, October 5. Roth Capital has “Buy” rating and $90 target. The company was maintained on Friday, August 25 by Cantor Fitzgerald. See Spark Therapeutics, Inc. (NASDAQ:ONCE) latest ratings:

08/03/2018 Broker: Credit Suisse Old Rating: Outperform New Rating: Outperform Old Target: $61 New Target: $75 Maintain
21/02/2018 Broker: Bernstein Rating: Buy New Target: $60.0 Maintain
21/02/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $64.0 Maintain
21/02/2018 Broker: BMO Capital Markets Old Rating: Outperform New Rating: Outperform Old Target: $66 New Target: $64 Maintain
20/02/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $100.0 Maintain
14/02/2018 Broker: J.P. Morgan Rating: Hold New Target: $60.0 Downgrade
14/02/2018 Broker: JP Morgan Old Rating: Overweight New Rating: Neutral Downgrade
12/02/2018 Broker: Mizuho Rating: Buy New Target: $79.0 Initiate
08/02/2018 Broker: RBC Capital Markets Rating: Buy New Target: $65.0 Reinitiate
25/01/2018 Broker: Barclays Capital Old Rating: Overweight New Rating: Overweight Old Target: $61 New Target: $64 Maintain

Curbstone Financial Management Corp increased J.M. Smuckers Co (Sjm) (SJM) stake by 115.54% reported in 2017Q3 SEC filing. Curbstone Financial Management Corp acquired 7,210 shares as J.M. Smuckers Co (Sjm) (SJM)’s stock declined 7.31%. The Curbstone Financial Management Corp holds 13,450 shares with $1.41M value, up from 6,240 last quarter. J.M. Smuckers Co (Sjm) now has $14.83B valuation. The stock increased 0.46% or $0.6 during the last trading session, reaching $130.52. About 544,056 shares traded. The J. M. Smucker Company (NYSE:SJM) has declined 0.84% since March 12, 2017 and is downtrending. It has underperformed by 17.54% the S&P500.

Investors sentiment decreased to 1.43 in Q3 2017. Its down 1.51, from 2.94 in 2017Q2. It turned negative, as 17 investors sold Spark Therapeutics, Inc. shares while 19 reduced holdings. 46 funds opened positions while 60 raised stakes. 33.64 million shares or 23.59% more from 27.22 million shares in 2017Q2 were reported. Highland Cap Mngmt Lp, Texas-based fund reported 45,000 shares. Citigroup, a New York-based fund reported 36,392 shares. Alps Advisors Inc holds 35,281 shares. Manufacturers Life Insurance Company The stated it has 0% in Spark Therapeutics, Inc. (NASDAQ:ONCE). Ubs Asset Management Americas Inc invested in 137,603 shares or 0.01% of the stock. Proshare Advsrs Limited reported 0.02% in Spark Therapeutics, Inc. (NASDAQ:ONCE). Royal Bank Of Canada has invested 0% in Spark Therapeutics, Inc. (NASDAQ:ONCE). Swiss Bancorp reported 51,400 shares or 0.01% of all its holdings. Millennium Mgmt Ltd has 242,952 shares. 27,445 were accumulated by Eam Invsts Ltd Limited Liability Company. Victory Mngmt accumulated 0.07% or 335,444 shares. Vanguard Grp holds 2.47M shares or 0.01% of its portfolio. Principal Group invested 0% of its portfolio in Spark Therapeutics, Inc. (NASDAQ:ONCE). Moreover, Invesco has 0% invested in Spark Therapeutics, Inc. (NASDAQ:ONCE) for 128,671 shares. Prudential Financial reported 0% of its portfolio in Spark Therapeutics, Inc. (NASDAQ:ONCE).

Spark Therapeutics, Inc. focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. The company has market cap of $2.31 billion. The Company’s products include voretigene neparvovec, which is in Phase III clinical trial for the treatment of genetic blinding conditions called inherited retinal diseases caused by non sex-linked, autosomal recessive, or biallelic mutations in the RPE65 gene; and SPK-CHM that is in Phase I/II clinical trial for the treatment of choroideremia. It currently has negative earnings. The companyÂ’s products also comprise SPK-7001 that is in Phase 1/2 trial for choroideremia; SPK-9001, which is in Phase 1/2 trial for hemophilia B; and SPK-8011 that is in Phase 1/2 trial hemophilia A.

The stock increased 0.56% or $0.34 during the last trading session, reaching $61.92. About 298,754 shares traded. Spark Therapeutics, Inc. (NASDAQ:ONCE) has risen 13.53% since March 12, 2017 and is uptrending. It has underperformed by 3.17% the S&P500.

Investors sentiment increased to 0.94 in 2017 Q3. Its up 0.05, from 0.89 in 2017Q2. It improved, as 71 investors sold SJM shares while 231 reduced holdings. 80 funds opened positions while 189 raised stakes. 83.48 million shares or 2.45% more from 81.49 million shares in 2017Q2 were reported. Kayne Anderson Rudnick Investment Mngmt Limited Co holds 38,724 shares. Orrstown Fincl Serv Inc owns 5,753 shares or 0.67% of their US portfolio. Baystate Wealth Ltd Company has invested 0% in The J. M. Smucker Company (NYSE:SJM). Qci Asset Mngmt Ny invested 0% in The J. M. Smucker Company (NYSE:SJM). 1,765 were reported by Adirondack Tru. First Merchants Corp stated it has 38,629 shares or 0.7% of all its holdings. Credit Suisse Ag invested in 276,502 shares. Lsv Asset, Illinois-based fund reported 1.44M shares. Fayerweather Charles stated it has 1.4% of its portfolio in The J. M. Smucker Company (NYSE:SJM). Shine Advisory Incorporated reported 244 shares stake. Legacy Prtn Inc holds 11,939 shares or 0.66% of its portfolio. Mitsubishi Ufj Trust & Bk Corporation holds 300,000 shares. Comerica Savings Bank has 0.03% invested in The J. M. Smucker Company (NYSE:SJM). Cordasco Net invested in 0% or 7 shares. 28,923 were reported by Thompson Investment Mgmt.

Among 20 analysts covering J. M. Smucker Company (NYSE:SJM), 6 have Buy rating, 4 Sell and 10 Hold. Therefore 30% are positive. J. M. Smucker Company has $152 highest and $106 lowest target. $128.15’s average target is -1.82% below currents $130.52 stock price. J. M. Smucker Company had 71 analyst reports since August 19, 2015 according to SRatingsIntel. The firm has “Sell” rating given on Monday, April 4 by Goldman Sachs. Stifel Nicolaus maintained the stock with “Hold” rating in Thursday, January 25 report. The firm has “Equal-Weight” rating given on Tuesday, February 20 by Barclays Capital. On Tuesday, September 27 the stock rating was downgraded by Credit Suisse to “Neutral”. The stock of The J. M. Smucker Company (NYSE:SJM) earned “Outperform” rating by Credit Agricole on Wednesday, September 2. Jefferies maintained The J. M. Smucker Company (NYSE:SJM) on Wednesday, August 30 with “Buy” rating. The rating was maintained by Morgan Stanley with “Underweight” on Friday, October 13. On Wednesday, June 7 the stock rating was maintained by Susquehanna with “Hold”. The stock of The J. M. Smucker Company (NYSE:SJM) has “Equal-Weight” rating given on Friday, June 3 by Morgan Stanley. The rating was downgraded by Stephens on Wednesday, July 19 to “Equal-Weight”.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: